체외 진단 (IVD) 분석기 시장조사 보고서

Report Highlights

The global market for In Vitro Diagnostics (IVD) analyzers is estimated to increase from $12.9 billion in 2023 to reach $16.3 billion by 2028, at a compound annual growth rate (CAGR) of 4.7% from 2023 through 2028.

Summary:

The global market for IVD analyzers was valued at $REDACTED billion in 2022, and is projected to reach $REDACTED billion by the end of 2028 at a CAGR of REDACTED % during the forecast period of 2023 to 2028. The increasing elderly population, growing incidence of chronic diseases, widening use of diagnostics for prevention and monitoring, and growing adoption of PoC testing are driving market growth.

Based on analyzer type, the market is categorized into immunoassay analyzers, clinical chemistry analyzers, hematology and hemostasis analyzers, molecular diagnostic analyzers and PoC analyzers. The molecular analyzers segment, which held the third largest market share in 2022, is expected to show the highest CAGR, at REDACTED%, during the forecast period. This segment’s share is attributed to the growing incidence of cancer and cancer-related diseases.

The market is also segmented into semi-automated and fully automated analyzers. The semi-automated segment accounted for REDACTED% of the market in 2022. The fully automated segment is expected to grow at a higher CAGR of REDACTED% during the forecast period, due to an increasing focus on automated and modulator laboratories. Its market share is expected to increase to REDACTED% in 2028, up from REDACTED% in 2022.

Based ontherapeutic area, the market for IVD analyzers is segmented into infectious diseases, diabetes, cardiology, oncology, nephrology and others. Infectious diseases accounted for REDACTED of the market in 2022 and this segment is expected to grow at a CAGR of REDACTED% during the forecast period. The diabetes segment is a distant second, with REDACTED% of the market in 2022, and it is expected to grow at a CAGR of REDACTED% during the forecast period.

In this report, the end users of IVD analyzers consist of diagnostic laboratories, hospitals and clinics, research institutions, and others. Diagnostic labs accounted for REDACTED% of the market share in 2022, and the segment is expected to grow at a CAGR of 5.0% during the forecast period. The increasing number of large laboratory networks with advanced instruments is driving the growth of this segment.

Leading companies in the IVD analyzers market include Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Beckman Coulter Diagnostics, Becton, Dickinson and Co., Bio-Rad Laboratories and Sysmex Corp.

Report Scope:

The current report highlights the current and future market potential of in vitro diagnostics analyzers along with an analysis of the drivers, restraints, challenges, and emerging trends in the market. The report segments the market for IVD analyzers based on analyzer type, level of automation, design, therapeutic area, and end user. The market is segmented into immunoassay analyzers, clinical chemistry, hematology and coagulation, molecular diagnostics, PoC analyzers and others based on test type. Based on level of automation, analyzers are categorized into semi-automated and fully automated. Based on therapeutic area, the market is segmented into infectious diseases, diabetes, oncology, cardiology, nephrology, and others. The market is segmented into diagnostic centers, hospitals and clinics, research institutions and others based on end user. The report includes profiles of the leading companies with information about their business segments, financials, product portfolios, and recent developments.

By geography, the market has been segmented into North America, Europe, Asia-Pacific, and rest of the world (RoW). The North America region includes the U.S., Canada, and Mexico. Europe includes Germany, the U.K., France, and the rest of Europe. The Asia-Pacific region includes China, India, Japan, and the rest of Asia-Pacific.

Report Synopsis

Report Includes:

• 39 data tables and 34 additional tables
• An analysis of the global market for in vitro diagnostics (IVD) analyzers
• Analyses of global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Estimate of the actual market size and revenue forecast, and corresponding market share analysis by test type, level of automation, application, end user and region
• Facts and figures pertaining to the market growth drivers, opportunities and restraints, innovations and prospects, technologies, regulatory scenarios, and COVID-19’s impact on the IVD industry
• Discussion of sustainability trends and factors in the IVD analyzer market, with emphasis on consumer attitudes, companies’ ESG scores, future of ESG, case studies and the ESG practices of leading companies
• Overview of the emerging new technologies and patents in the market
• Analysis of the major vendors in the market as well as the competitive landscape, including company market shares, financials, M&A deals and venture fundings
• Profiles of the leading market players, including Siemens Healthineers, Abbott Laboratories, F. Hoffmann-La Roche, Bio-Rad Laboratories, Danaher Corp., and Thermo Fisher Scientific

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What’s New in this Update
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Highlights of the Market for IVD Analyzers
Chapter 3 Market Overview
Overview
Chapter 4 Market Dynamics
Market Dynamics
Market Drivers
Market Challenges
Chapter 5 Market Breakdown by Analyzer Type
Global Market for IVD Analyzers
Market Analysis
Immunoassay Analyzers
Market Size and Forecast
Clinical Chemistry Analyzers
Market Forecast
Hematology and Hemostasis Analyzers
Market Forecast
Molecular Diagnostic Analyzers
Market Forecast
Point-of-Care Analyzers
Market Forecast
Other Analyzers
Market Forecast
Chapter 6 Market Breakdown by Level of Automation
Introduction
Semi-Automated Analyzers
Fully Automated Analyzers
Chapter 7 Market Breakdown by Therapeutic Area
Introduction
Infectious Diseases
Diabetes
Oncology
Cardiology
Nephrology
Other Therapeutic Areas
Chapter 8 Market Breakdown by End User
Introduction
Diagnostic Labs
Hospitals and Clinics
Research Institutions
Other Users
Chapter 9 Market Breakdown by Region
Introduction
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Rest of Europe
Asia-Pacific
China
Australia
Japan
Rest of Asia-Pacific
Rest of the World
Chapter 10 ESG Development
Introduction to ESG
Sustainability in the IVD Analyzer Industry: An ESG Perspective
Key ESG Issues
Environmental Performance of IVD Companies
Social Performance of Key IVD Analyzers Companies
Governance Performance of IVD Analyzer Companies
Consumer Attitudes toward ESG in the IVD Analyzer Market
Case Study
Concluding Remarks from BCC Research
Chapter 11 Emerging Technologies and Developments
Technologies in the Market
Integration of AI and Machine Learning
Digital Morphology
Connected PoC Devices
Microfluidics and Miniaturization
Chapter 12 Regulatory Scenario
IVD Regulations in North America
United States
Canada
Mexico
IVD Regulations in Europe
IVD Regulations in Asia-Pacific
Japan
China
India
Australia
Malaysia
Singapore
IVD Regulations in RoW
Brazil
Israel
Saudi Arabia
South Africa
Chapter 13 M&A Analysis
M&A Analysis
Chapter 14 Competitive Landscape
Market Share Analysis
Partnerships and Alliances
Chapter 15 Company Profiles
ABBOTT DIAGNOSTICS SCARBOROUGH INC.
BECTON, DICKINSON AND CO.
BIOMÉRIEUX
BIO-RAD LABORATORIES INC.
DANAHER CORP.
EKF DIAGNOSTICS HOLDINGS PLC
F. HOFFMANN-LA ROCHE LTD.
QUIDELORTHO CORP.
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
SIEMENS HEALTHINEERS AG
SYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.

List of Tables
Summary Table A : Global Market for IVD Analyzers, by Analyzer Type, Through 2028
Summary Table B : Global Market for IVD Analyzers, by Region, Through 2028
Table 1 : Global Market for IVD Analyzers, by Analyzer Type, Through 2028
Table 2 : Global Market for Immunoassay Analyzers, by Region, Through 2028
Table 3 : Analytes Tested in Clinical Chemistry Laboratories
Table 4 : Global Market for Clinical Chemistry Analyzers, by Region, Through 2028
Table 5 : Global Market for Hematology and Hemostasis Analyzers, by Region, Through 2028
Table 6 : Global Market for Molecular Diagnostic Analyzers, by Region, Through 2028
Table 7 : Global Market for PoC Analyzers, by Region, Through 2028
Table 8 : Global Market for Other Analyzers, by Region, Through 2028
Table 9 : Global Market for IVD Analyzers, by Level of Automation, Through 2028
Table 10 : Global Market for Semi-automated Analyzers, by Region, Through 2028
Table 11 : Global Market for Fully Automated Analyzers, by Region, Through 2028
Table 12 : Global Market for IVD Analyzers, by Therapeutic Area, Through 2028
Table 13 : Global Market for IVD Analyzers for Infectious Diseases, by Region, Through 2028
Table 14 : Global Market for IVD Analyzers for Diabetes, by Region, Through 2028
Table 15 : Global Market for IVD Analyzers for Oncology, by Region, Through 2028
Table 16 : Global Market for IVD Analyzers for Cardiology, by Region, Through 2028
Table 17 : Global Market for IVD Analyzers for Nephrology, by Region, Through 2028
Table 18 : Global Market for IVD Analyzers for Other Therapeutic Areas, by Region, Through 2028
Table 19 : Global Market for IVD Analyzers, by End User, Through 2028
Table 20 : Global Market for IVD Analyzers Used in Diagnostic Labs, by Region, Through 2028
Table 21 : Global Market for IVD Analyzers Used in Hospitals and Clinics, by Region, Through 2028
Table 22 : Global Market for IVD Analyzers Used in Research Institutions, by Region, Through 2028
Table 23 : Global Market for IVD Analyzers Used by Other End Users, by Region, Through 2028
Table 24 : Global Market for IVD Analyzers, by Region, Through 2028
Table 25 : North American Market for IVD Analyzers, by Country, Through 2028
Table 26 : European Market for IVD Analyzers, by Country, Through 2028
Table 27 : Asia-Pacific Market for IVD Analyzers, by Country, Through 2028
Table 28 : Focus Areas in ESG Metrics
Table 29 : ESG Rankings for Major IVD Analyzer Companies, 2023*
Table 30 : ESG: Environmental Overview
Table 31 : ESG: Social Overview
Table 32 : ESG: Governance Overview
Table 33 : bioMérieux: Certifications and Indices Received, 2022
Table 34 : Developments in Digital Morphology, 2023
Table 35 : Recent Developments in Connected PoC Devices, 2023
Table 36 : Recent Developments in the Application of Microfluidics and Miniaturization, 2023
Table 37 : M&A in the IVD Analyzer Market, 2021-2023
Table 38 : Key Alliances and Partnerships in IVD Analyzers Market, 2021-2023
Table 39 : Abbott Laboratories: Financials, 2021 and 2022
Table 40 : Abbott Laboratories: Product Portfolio
Table 41 : Becton, Dickinson, and Co.: Financials, 2021 and 2022
Table 42 : Becton, Dickinson, and Co.: Product Portfolio
Table 43 : bioMérieux SA: Financials, 2021 and 2022
Table 44 : bioMérieux SA: Product Portfolio
Table 45 : Bio-Rad Laboratories: Financials, 2021 and 2022
Table 46 : Bio-Rad Laboratories: Product Portfolio
Table 47 : Bio-Rad Laboratories: Recent Developments, 2022
Table 48 : Danaher Corp.: Financials, 2021 and 2022
Table 49 : Danaher Corp.: Product Portfolio
Table 50 : Danaher Corp.: Recent Developments, 2023
Table 51 : EKF Diagnostics Holdings: Financials, 2021 and 2022
Table 52 : EKF Diagnostics Holdings: Product Portfolio
Table 53 : EKF Diagnostics Holdings: Recent Developments, 2022
Table 54 : F. Hoffmann-La Roche: Financials, 2021 and 2022
Table 55 : F. Hoffmann-La Roche: Product Portfolio
Table 56 : F. Hoffmann-La Roche: Recent Developments, 2023
Table 57 : QuidelOrtho Corp.: Financials, 2021 and 2022
Table 58 : QuidelOrtho Corp.: Product Portfolio
Table 59 : QuidelOrtho Corp.: Recent Developments, 2023
Table 60 : Shenzhen Mindray Bio-Medical Electronics: Product Portfolio
Table 61 : Shenzhen Mindray Bio-Medical Electronics: Recent Developments, 2023
Table 62 : Siemens Healthineers: Financials, 2021 and 2022
Table 63 : Siemens Healthineers: Product Portfolio
Table 64 : Siemens Healthineers.: Recent Developments, 2023
Table 65 : Sysmex Corp.: Financials, 2021 and 2022
Table 66 : Sysmex Corp.: Product Portfolio
Table 67 : Sysmex Corp.: Recent Developments, 2023
Table 68 : Thermo Fisher Scientific: Financials, 2021 and 2022
Table 69 : Thermo Fisher Scientific: Product Portfolio
Table 70 : Thermo Fisher Scientific: Recent Developments, 2023

List of Figures
Summary Figure A : Global Market for IVD Analyzers, by Analyzer Type, 2020-2028
Summary Figure B : Global Market for IVD Analyzers, by Region, 2020-2028
Figure 1 : Role of In Vitro Diagnostics Tests
Figure 2 : Global Market Shares of IVD Analyzers, by Analyzer Type, 2022
Figure 3 : Global Market for Immunoassay Analyzers, by Region, 2020-2028
Figure 4 : Global Market Shares of Immunoassay Analyzers, by Region, 2022
Figure 5 : Global Market for Clinical Chemistry Analyzers, by Region, 2020-2028
Figure 6 : Global Market Shares of Clinical Chemistry Analyzers, by Region, 2022
Figure 7 : Global Market for Hematology and Hemostasis Analyzers, by Region, 2020-2028
Figure 8 : Global Market Shares of Hematology and Hemostasis Analyzers, by Region, 2022
Figure 9 : Global Market for Molecular Diagnostic Analyzers, by Region, 2020-2028
Figure 10 : Global Market Shares of Molecular Diagnostic Analyzers, by Region, 2022
Figure 11 : Global Market for PoC Analyzers, by Region, 2020-2028
Figure 12 : Global Market Shares of PoC Analyzers, by Region, 2022
Figure 13 : Global Market for Other Analyzers, by Region, 2020-2028
Figure 14 : Global Market Shares of Other Analyzers, by Region, 2022
Figure 15 : Global Market for Semi-Automated Analyzers, 2020-2028
Figure 16 : Global Market for Fully Automated Analyzers, 2020-2028
Figure 17 : Global Market Shares of IVD Analyzers, by Therapeutic Area, 2022
Figure 18 : Global Market for IVD Analyzers for Infectious Diseases, 2020-2028
Figure 19 : Global Market for IVD Analyzers for Diabetes, 2020-2028
Figure 20 : Global Market for IVD Analyzers for Oncology, 2020-2028
Figure 21 : Global Market for IVD Analyzers for Cardiology, 2020-2028
Figure 22 : Global Market for IVD Analyzers for Nephrology, 2020-2028
Figure 23 : Global Market for IVD Analyzers for Other Therapeutic Areas, 2020-2028
Figure 24 : Global Market Shares of IVD Analyzers, by End User, 2022
Figure 25 : Global Market for IVD Analyzers, by End User, 2020-2028
Figure 26 : Global Market for IVD Analyzers Used in Diagnostic Labs, 2020-2028
Figure 27 : Global Market for IVD Analyzers Used in Hospitals and Clinics, 2020-2028
Figure 28 : Global Market for IVD Analyzers Used in Research Institutions, 2020-2028
Figure 29 : Global Market for IVD Analyzers Used by Other End Users, 2020-2028
Figure 30 : Global Market Shares of IVD Analyzers, by Region, 2022
Figure 31 : North American Market Shares of IVD Analyzers, by Country, 2022
Figure 32 : U.S. Market for IVD Analyzers, 2020-2028
Figure 33 : Canadian Market for IVD Analyzers, 2020-2028
Figure 34 : Mexican Market for IVD Analyzers, 2020-2028
Figure 35 : European Market Shares of IVD Analyzers, by Country, 2022
Figure 36 : German Market for IVD Analyzers, 2020-2028
Figure 37 : U.K. Market for IVD Analyzers, 2020-2028
Figure 38 : French Market for IVD Analyzers, 2020-2028
Figure 39 : Rest of Europe Market for IVD Analyzers, 2020-2028
Figure 40 : Asia-Pacific Market Shares of IVD Analyzers, by Country, 2022
Figure 41 : Chinese Market for IVD Analyzers, 2020-2028
Figure 42 : Australian Market for IVD Analyzers, 2020-2028
Figure 43 : Japanese Market for IVD Analyzers, 2020-2028
Figure 44 : Rest of Asia-Pacific Market for IVD Analyzers, 2020-2028
Figure 45 : RoW Market for IVD Analyzers, 2020-2028
Figure 46 : ESG Pillars
Figure 47 : Advantages of ESG for IVD Analyzer Companies
Figure 48 : ESG-Adoption Level Across All Industries, Global, 2021 and 2022
Figure 49 : bioMérieux: ESG Aspects
Figure 50 : bioMérieux ESG Indicators, 2022
Figure 51 : Emerging Technologies in the IVD Analyzer Market
Figure 52 : Global Market Shares of IVD Analyzers, by Company, 2022
Figure 53 : Abbott Laboratories: Financials, 2021 and 2022
Figure 54 : Abbott Laboratories: Market Share, by Business Segment, 2022
Figure 55 : Abbott Laboratories: Market Share of Diagnostics Segment, by Region, 2022
Figure 56 : Abbott Laboratories: Market Share of Diagnostics Segment, 2022
Figure 57 : Becton, Dickinson, and Co.: Financials, 2021 and 2022
Figure 58 : Becton, Dickinson and Co.: Market Share, by Region, 2022
Figure 59 : Becton, Dickinson, and Co.: Market Share, by Business Segment, 2022
Figure 60 : bioMérieux SA: Financials, 2021 and 2022
Figure 61 : bioMérieux SA: Market Share, by Business Segment, 2022
Figure 62 : bioMérieux SA: Market Share, by Region, 2022
Figure 63 : Bio-Rad Laboratories: Financials, 2021 and 2022
Figure 64 : Bio-Rad Laboratories: Market Share, by Business Segment, 2022
Figure 65 : Bio-Rad Laboratories: Revenue Share, by Region, 2022
Figure 66 : Danaher Corp.: Financials, 2021 and 2022
Figure 67 : Danaher Corp.: Market Share, by Region, 2022
Figure 68 : Danaher Corp.: Market Share, by Business Segment, 2022
Figure 69 : EKF Diagnostics Holdings: Financials, 2021 and 2022
Figure 70 : EKF Diagnostics Holdings: Market Share, by Region, 2022
Figure 71 : EKF Diagnostics Holdings: Market Share, by Business Segment, 2022
Figure 72 : F. Hoffmann-La Roche: Financials, 2021 and 2022
Figure 73 : F. Hoffmann-La Roche: Market Share, by Region, 2022
Figure 74 : F. Hoffmann-La Roche: Market Share, by Diagnostics Business Segment, 2022
Figure 75 : QuidelOrtho Corp: Financials, 2021 and 2022
Figure 76 : QuidelOrtho Corp.: Market Share, by Region, 2022
Figure 77 : QuidelOrtho Corp.: Market Share, by Business Segment, 2022
Figure 78 : Siemens Healthineers: Financials, 2021 and 2022
Figure 79 : Siemens Healthineers: Market Share, by Business Segment, 2022
Figure 80 : Siemens Healthineers: Market Share, by Region, 2022
Figure 81 : Sysmex Corp.: Financials, 2021 and 2022
Figure 82 : Sysmex Corp.: Market Share, by Region, 2022
Figure 83 : Sysmex Corp.: Revenue Share, by Business Segment, 2022
Figure 84 : Thermo Fisher Scientific: Financials, 2021 and 2022
Figure 85 : Thermo Fisher Scientific: Market Share, by Region, 2022
Figure 86 : Thermo Fisher Scientific: Market Share, by Business Segment, 2022
Figure 87 : Thermo Fisher Scientific: Market Share, by Product Segment, 2022